Scheduling Periodic Examinations for the Early Detection of Disease: Applications to Breast Cancer

Journal of the American Statistical Association

Volumn 93, Issue 444, 1998, Pages 1271-1281

  Lee, Sandra J ^a   Zelen, Marvin ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Periodic screening

Indexed keywords

EID: 0032264035     PISSN: 01621459     EISSN: 1537274X     Source Type: Journal    
DOI: 10.1080/01621459.1998.10473788     Document Type: Article

References (27)

1. Albert, A., Gertman, P. M., Louis, T., and Liu, S. (1978), “Screening for the Early Detection of Cancer II. The Impact of Screening in the Natural History of the Disease,” Mathematical Bioscience, 40, 61-109.
2. Baker, S. G., and Chu, K. C. (1990), “Evaluating Screening for the Early Detection and Treatment of Cancer Without Using a Randomized Control Group,” Journal of the American Statistical Association, 85, 321-327.
3. Day, N. E., and Walter, S. D. (1984), “Simplified Models of Screening of Chronic Disease: Estimation Procedures From Mass Screening Programmes,” Biometrics, 40, 1-13.
4. Day, N. E., Walter, S. D., and Tabar, L. (1988), “The Sensitivity and Lead Time of Breast Cancer Screening: A Comparison of the Results of Different Studies,” in Screening for Breast Cancer, eds. N. E. Day and A. B. Miller, Stuttgart: Hans Huber, pp. 105-109.
5. Dubin, N. (1981), “Predicting the Benefit of Screening for Disease,” Journal of Applied Probability, 18, 348-360.
6. Eddy, D. M. (1980), Screening for Cancer: Theory, Analysis and Design, Englewood Cliffs, NJ: Prentice-Hall.
7. Eddy, D. M. (1983), “A Mathematical Model for Timing Repeated Medical Tests,” Medical Decision Making, 3, 34-62.
8. Eddy, D. M., and Shwartz, M. (1982), “Mathematical Models in Screening,” in Cancer Epidemiology and Prevention, eds. W. Schottenfeld and J. Fraumeni, Philadelphia, PA: W. B. Saunders, pp. 1075-1090.
9. Fishel, R., Lescoe, M. K., Rao, M. R., Copeland, N. G., Jenkins, N. A., Garber, J., Kane, M., and Kolodmer, R. (1993), “The Human Mutation Gene Homolog MSH2 and Its Association With Nonpolyposis Colon Cancer,” Cell, 75, 1027-1038.
10. Fletcher, S. W., Black, W., Harris, R., Rimer, B. K., and Shapiro, S. (1993), “Report of the International Workshop on Screening for Breast Cancer,” Journal of the National Cancer Institute, 85, 1644-1656.
11. Gail, M. H., Brinton, L. A., Byar, D. P., Corle, D. K., Green, S. B., Schairer, C., and Mulvihill, J. J. (1989), “Projecting Individualized Probabilities of Developing Breast Cancer for White Females Who Are Being Examined Annually,” Journal of the National Cancer Institute, 81, 1879-1886.
12. Habbema, J. D. F., VanOortmarssen, G. J., Lubbe, J. T. N., and van der Mass, P. J. (1984), “The MISCAN Simulation Program for the Evaluation of Screening for Disease,” Computer Programs in Biomedicine (Vol. 9), Amsterdam, North-Holland.
13. Kirch, R. L. A., and Klein, M. (1974), “Examination Schedules for Breast Cancer,” Cancer, 33, 1444-1450.
14. Knox, E. G. (1973), “A Simulation System for Screening Procedures,” in The Future and Present Indicatives, Problems and Progress ih Medical Care, Ninth Series, Nuffield Provincial Hospitals Trust, ed. G. McLach-lan, London: Oxford University Press, pp. 17-55.
15. National Cancer Institute (1994), Surveillance, Epidemiology, and End Results Program. Age-Specific Rates for Breast Cancer. Bethesda, MD: Author.
16. NIH Consensus Statement (1997), Breast Cancer Screening for Women Ages 40-49, Bethesda, MD: National Cancer Institute.
17. Parmigiani, G. (1993), “On Optimal Screening Ages,” Journal of the American Statistical Association, 88, 622-628.
18. Parmigiani, G. (1997), “Timing Medical Examinations via Intensity Functions,” Biometrika, 84, 803-816.
19. Prorok, P. C. (1976a), “The Theory of Periodic Screening I. Lead Time and Proportion Detected,” Advanced Applied Probability, 8, 127-143.
20. Prorok, P. C. (1976b), “The Theory of Periodic Screening II. Doubly Bounded Recurrence Times and Mean Lead Time and Detection Probability Estimation,” Advanced Applied Probability, 8, 460-476.
21. Shwartz, M. (1978), “An Analysis of the Benefits of Serial Screening for Breast Cancer Based Upon a Mathematical Model of the Disease,” Cancer, 41, 1550-1564.
22. Shwartz, M., and Plough, A. L. (1984), “Models in Planning Cancer Programs,” in Statistical Methods for Cancer Studies, ed. R. G. Cornell, New York: Marcel Dekker, pp. 329-416.
23. Shapiro, S., Venet, W., Strax, P. H., Venet, L., and Rosener, R. (1982), 'Ten-to Fourteen-Year Effect of Screening on Breast Cancer Mortality,” Journal of the National Cancer Institute, 69, 349-355.
24. Struewing, J. P., Hartge, P., Wacholder, S., Baker, S. M., Berlim, M., McAdams, M., Timmerman, M. M., Brody, L. C., and Tucker, M. A. (1997), “The Risk of Cancer Associated With Specific Mutations of BRCA1 and BRCA2 Among Ashkenazi Jews,” New England Journal of Medicine, 11, 1401-1408.
25. Tabar, L., Fagerberg, C. J., Gad, A., Baldetorp, L., Holmberg, L. H., Grontoft, O., Ljungquist, U., Lundstrom, B., Mansom, J. C., and Ekhund, G. (1985), “Reduction in Mortality From Breast Cancer After Mass Screening With Mammography,” Lancet, 1, 829-832.
26. Zelen, M. (1993), “Optimal Scheduling of Examinations for the Early Detection of Disease,” Biometrika, 80, 279-293.
27. Zelen, M., and Feinleib, M. (1969), “On the Theory of Screening for Chronic Diseases,” Biometrika, 56, 601-614.